Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Stomatitis 10Multiple Myeloma 9Lymphoma, Non-Hodgkin 9Lymphoma 9Hodgkin Disease 9Leukemia, Myeloid, Acute 8Leukemia 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasms 7Mucositis 6Myelodysplastic Syndromes 5Lymphoma, Large B-Cell, Diffuse 5Head and Neck Neoplasms 5Neoplasms, Plasma Cell 4Leukemia, Lymphocytic, Chronic, B-Cell 4Recurrence 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Hematologic Neoplasms 3Burkitt Lymphoma 3Blast Crisis 3Radiation Injuries 2Lymphoma, T-Cell 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Graft vs Host Disease 2Drug-Related Side Effects and Adverse Reactions 2

Interventions

Fibroblast Growth Factor 7 1Denosumab 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cataract × Fibroblast Growth Factor 7 × Clear all
NCT00434161 2015-03-30

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma

Swedish Orphan Biovitrum

Phase 3 Completed
281 enrolled 27 charts
Plasma cell

Cataract, Multiple Myeloma, Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡